NCT05378321View on ClinicalTrials.gov

Prevalence of NAFLD in ACS Patients

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
NAFLDACS - Acute Coronary Syndrome
Interventions
DIAGNOSTIC_TEST

Non-invasive diagnostic testing

Non-invasive diagnostic testing consists of the use of the FibroScan device and the calculation of non-invasive blood-based scores for the diagnosis of NAFLD

Trial Locations (1)

3600

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
lead

Ziekenhuis Oost-Limburg

OTHER